Free Trial

PetVivo (PETV) Competitors

PetVivo logo
$0.78 +0.00 (+0.32%)
As of 07/3/2025 12:56 PM Eastern

PETV vs. NSPR, APYX, ZYXI, VANI, CTSO, INO, TELA, EDAP, MLSS, and MDAI

Should you be buying PetVivo stock or one of its competitors? The main competitors of PetVivo include InspireMD (NSPR), Apyx Medical (APYX), Zynex (ZYXI), Vivani Medical (VANI), Cytosorbents (CTSO), Inovio Pharmaceuticals (INO), TELA Bio (TELA), Edap Tms (EDAP), Milestone Scientific (MLSS), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.

PetVivo vs. Its Competitors

InspireMD (NYSE:NSPR) and PetVivo (NASDAQ:PETV) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, dividends, institutional ownership, earnings, risk, media sentiment, analyst recommendations and valuation.

InspireMD presently has a consensus target price of $4.50, suggesting a potential upside of 99.56%. Given InspireMD's stronger consensus rating and higher possible upside, analysts clearly believe InspireMD is more favorable than PetVivo.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
InspireMD
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
PetVivo
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

44.8% of InspireMD shares are held by institutional investors. Comparatively, 24.5% of PetVivo shares are held by institutional investors. 34.1% of InspireMD shares are held by insiders. Comparatively, 10.8% of PetVivo shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.

InspireMD has a beta of 0.57, indicating that its stock price is 43% less volatile than the S&P 500. Comparatively, PetVivo has a beta of 0.87, indicating that its stock price is 13% less volatile than the S&P 500.

PetVivo has lower revenue, but higher earnings than InspireMD. InspireMD is trading at a lower price-to-earnings ratio than PetVivo, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
InspireMD$7.03M9.83-$19.92M-$0.79-2.85
PetVivo$1.05M18.10-$10.95M-$0.45-1.73

In the previous week, PetVivo had 8 more articles in the media than InspireMD. MarketBeat recorded 8 mentions for PetVivo and 0 mentions for InspireMD. PetVivo's average media sentiment score of 0.16 beat InspireMD's score of 0.00 indicating that PetVivo is being referred to more favorably in the news media.

Company Overall Sentiment
InspireMD Neutral
PetVivo Neutral

InspireMD has a net margin of -413.96% compared to PetVivo's net margin of -902.82%. InspireMD's return on equity of -69.42% beat PetVivo's return on equity.

Company Net Margins Return on Equity Return on Assets
InspireMD-413.96% -69.42% -57.68%
PetVivo -902.82%-4,813.07%-281.78%

Summary

InspireMD beats PetVivo on 9 of the 16 factors compared between the two stocks.

Get PetVivo News Delivered to You Automatically

Sign up to receive the latest news and ratings for PETV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PETV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PETV vs. The Competition

MetricPetVivoSurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$18.93M$256.84M$5.50B$9.01B
Dividend YieldN/AN/A5.38%4.04%
P/E Ratio-1.735.9227.6020.30
Price / Sales18.1073.84369.09103.84
Price / CashN/A196.1236.6357.47
Price / Book-26.006.128.055.68
Net Income-$10.95M-$27.18M$3.18B$249.13M
7 Day Performance-1.23%-1.07%2.82%3.30%
1 Month Performance1.30%-7.07%3.70%5.20%
1 Year Performance65.25%25.77%35.41%21.38%

PetVivo Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PETV
PetVivo
N/A$0.78
+0.3%
N/A+65.3%$18.93M$1.05M-1.7320Gap Down
NSPR
InspireMD
3.2409 of 5 stars
$2.52
+2.4%
$4.50
+78.6%
-7.6%$77.20M$7.03M-3.3650
APYX
Apyx Medical
1.7295 of 5 stars
$2.00
flat
N/A+71.2%$75.59M$47.29M-3.64270
ZYXI
Zynex
2.6679 of 5 stars
$2.39
-4.0%
$6.00
+151.0%
-73.7%$75.30M$172.40M-9.96770Gap Down
VANI
Vivani Medical
2.838 of 5 stars
$1.26
flat
$4.00
+217.5%
+5.8%$74.65MN/A-2.9320High Trading Volume
CTSO
Cytosorbents
1.8413 of 5 stars
$1.26
+6.8%
$5.50
+336.5%
+20.9%$73.88M$35.60M-4.50220
INO
Inovio Pharmaceuticals
3.8853 of 5 stars
$1.93
-1.5%
$9.75
+405.2%
-82.8%$71.88M$220K-0.61320News Coverage
Gap Down
TELA
TELA Bio
2.6191 of 5 stars
$1.73
+4.8%
$7.25
+319.1%
-52.3%$65.27M$71.22M-1.23120Gap Up
EDAP
Edap Tms
2.4332 of 5 stars
$1.72
+1.3%
$8.50
+394.2%
-69.6%$63.49M$69.18M-2.77230
MLSS
Milestone Scientific
2.9725 of 5 stars
$0.80
-9.1%
$1.25
+56.4%
+1.5%$62.70M$8.61M-11.4130Gap Up
MDAI
Spectral AI
3.0348 of 5 stars
$2.05
-6.4%
$4.75
+131.7%
+44.7%$55.44M$29.58M-3.8083Analyst Revision

Related Companies and Tools


This page (NASDAQ:PETV) was last updated on 7/4/2025 by MarketBeat.com Staff
From Our Partners